Sippican Capital Advisors Gilead Sciences, Inc. Transaction History

Sippican Capital Advisors

  • $130 Million
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024
SELL
$71.58 - $87.29 $1.24 Million - $1.51 Million
-17,346 Reduced 81.48%
3,942 $288,000
Q4 2023

Jan 30, 2024
SELL
$73.27 - $83.09 $13,188 - $14,956
-180 Reduced 0.84%
21,288 $1.72 Million
Q2 2023

Aug 15, 2023
SELL
$76.01 - $86.7 $59,591 - $67,972
-784 Reduced 3.52%
21,468 $1.65 Million
Q1 2023

Jul 14, 2023
SELL
$77.31 - $88.08 $322,150 - $367,029
-4,167 Reduced 15.77%
22,252 $1.85 Million
Q4 2022

Jan 26, 2023
SELL
$62.32 - $89.47 $135,857 - $195,044
-2,180 Reduced 7.62%
26,419 $0
Q3 2022

Oct 17, 2022
BUY
$59.54 - $68.01 $43,285 - $49,443
727 Added 2.61%
28,599 $1.76 Million
Q2 2022

Jul 19, 2022
BUY
$57.72 - $65.01 $96,219 - $108,371
1,667 Added 6.36%
27,872 $1.72 Million
Q1 2022

Apr 20, 2022
BUY
$57.92 - $72.58 $352,327 - $441,504
6,083 Added 30.23%
26,205 $1.56 Million
Q4 2021

Jan 19, 2022
BUY
$64.88 - $73.64 $21,994 - $24,963
339 Added 1.71%
20,122 $1.46 Million
Q3 2021

Oct 20, 2021
SELL
$67.69 - $73.03 $21,999 - $23,734
-325 Reduced 1.62%
19,783 $1.38 Million
Q2 2021

Jul 22, 2021
SELL
$63.47 - $69.35 $52,680 - $57,560
-830 Reduced 3.96%
20,108 $1.39 Million
Q1 2021

Apr 15, 2021
BUY
$60.0 - $68.46 $201,420 - $229,820
3,357 Added 19.09%
20,938 $1.35 Million
Q4 2020

Jan 21, 2021
BUY
$56.65 - $64.55 $79,763 - $90,886
1,408 Added 8.71%
17,581 $1.02 Million
Q3 2020

Oct 23, 2020
BUY
$62.1 - $78.08 $42,724 - $53,719
688 Added 4.44%
16,173 $1.02 Million
Q2 2020

Jul 15, 2020
SELL
$72.34 - $84.0 $58,595 - $68,040
-810 Reduced 4.97%
15,485 $1.19 Million
Q1 2020

Apr 16, 2020
SELL
$62.63 - $80.22 $231,668 - $296,733
-3,699 Reduced 18.5%
16,295 $1.22 Million
Q4 2019

Jan 21, 2020
SELL
$61.62 - $67.78 $179,992 - $197,985
-2,921 Reduced 12.75%
19,994 $1.3 Million
Q3 2019

Oct 17, 2019
BUY
$62.51 - $69.0 $30,004 - $33,120
480 Added 2.14%
22,915 $1.45 Million
Q2 2019

Jul 17, 2019
SELL
$61.87 - $69.38 $118,852 - $133,278
-1,921 Reduced 7.89%
22,435 $1.52 Million
Q1 2019

Apr 17, 2019
SELL
$62.53 - $70.05 $6,002 - $6,724
-96 Reduced 0.39%
24,356 $1.58 Million
Q4 2018

Jan 16, 2019
BUY
$60.54 - $79.0 $2,421 - $3,160
40 Added 0.16%
24,452 $1.53 Million
Q3 2018

Nov 13, 2018
BUY
$71.28 - $78.92 $3,207 - $3,551
45 Added 0.18%
24,412 $1.76 Million
Q2 2018

Jul 17, 2018
BUY
$64.88 - $75.68 $191,525 - $223,407
2,952 Added 13.78%
24,367 $1.73 Million
Q1 2018

Apr 24, 2018
BUY
$72.84 - $88.8 $51,862 - $63,225
712 Added 3.44%
21,415 $1.61 Million
Q4 2017

Jan 17, 2018
BUY
$71.15 - $83.52 $156,814 - $184,078
2,204 Added 11.91%
20,703 $1.48 Million
Q3 2017

Oct 30, 2017
BUY
$72.11 - $85.47 $1.33 Million - $1.58 Million
18,499
18,499 $1.5 Million

Others Institutions Holding GILD

# of Institutions
1,893
Shares Held
1.02B
Call Options Held
12M
Put Options Held
9.04M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sippican Capital Advisors Portfolio

Follow Sippican Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sippican Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Sippican Capital Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email